Reelin expression and glycosylation patterns are altered in Alzheimer's disease - Wikidata - wikimedia - TriplyDB

Reelin expression and glycosylation patterns are altered in Alzheimer's disease

Reelin expression and glycosylation patterns are altered in Alzheimer's disease

http://www.wikidata.org/entity/Q24541523

about

sameAs

The involvement of Reelin in neurodevelopmental disorders.The Reelin signaling pathway promotes dendritic spine development in hippocampal neurons Interaction of reelin with amyloid precursor protein promotes neurite outgrowth Structure of a receptor-binding fragment of reelin and mutational analysis reveal a recognition mechanism similar to endocytic receptors Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin Canonical and Non-canonical Reelin Signaling Pathophysiological Function of ADAMTS Enzymes on Molecular Mechanism of Alzheimer's Disease Reelin Proteolysis Affects Signaling Related to Normal Synapse Function and Neurodegeneration Docosahexaenoic Acid and Cognition throughout the Lifespan Regulated proteolytic processing of Reelin through interplay of tissue plasminogen activator (tPA), ADAMTS-4, ADAMTS-5, and their modulators Reelin and Neuropsychiatric Disorders.Reelin supplementation enhances cognitive ability, synaptic plasticity, and dendritic spine density.Reelin signaling facilitates maturation of CA1 glutamatergic synapses Exploring the use of social media to measure journal article impact Reelin supplementation recovers sensorimotor gating, synaptic plasticity and associative learning deficits in the heterozygous reeler mouse.Intersectin 1 is a component of the Reelin pathway to regulate neuronal migration and synaptic plasticity in the hippocampus Reelin demarcates a subset of pre-Bötzinger complex neurons in adult rat Reelin Signaling, Hippocampal Neurogenesis, and Efficacy of Aspirin Intake & Stem Cell Transplantation in Aging and Alzheimer's disease.Quantifying proteins by mass spectrometry: the selectivity of SRM is only part of the problem Glycans in sera of amyotrophic lateral sclerosis patients and their role in killing neuronal cells Searching for reliable premortem protein biomarkers for prion diseases: progress and challenges to date.Accelerating neuronal aging in in vitro model brain disorders: a focus on reactive oxygen species More than cholesterol transporters: lipoprotein receptors in CNS function and neurodegeneration The extremely conserved C-terminal region of Reelin is not necessary for secretion but is required for efficient activation of downstream signaling.Beta-amyloid impairs reelin signaling.A quantitative proteomic approach to prion disease biomarker research: delving into the glycoproteome.Identification of a 31-bp deletion in the RELN gene causing lissencephaly with cerebellar hypoplasia in sheep.Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative disease Extracellular proteolysis of reelin by tissue plasminogen activator following synaptic potentiation Increased Blood-Reelin-Levels in First Episode Schizophrenia Reelin-mediated Signaling during Normal and Pathological Forms of Aging ApoER2 expression increases Abeta production while decreasing Amyloid Precursor Protein (APP) endocytosis: Possible role in the partitioning of APP into lipid rafts and in the regulation of gamma-secretase activity.Reelin protects against amyloid β toxicity in vivo Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease Mass spectrometry-based proteomics and peptidomics for biomarker discovery in neurodegenerative diseases Comparative glycoproteomics: approaches and applications.The β-amyloid peptide compromises Reelin signaling in Alzheimer's disease.Neurochemical approaches in the laboratory diagnosis of Parkinson and Parkinson dementia syndromes: a review Reelin immunoreactivity in neuritic varicosities in the human hippocampal formation of non-demented subjects and Alzheimer's disease patients.Characterization of G protein-coupled receptor 56 protein expression in the mouse developing neocortex

P2860

Q24632484-5FB45F3D-CB79-4F99-8317-00D01899AF46 Q24648455-5632CA1B-F867-45A6-B25C-111521302089 Q24655186-9114901E-BEBC-4121-816C-B7D6C0219D82 Q24673808-D99CBDA7-7189-4058-B0BD-0BBE7FB7E2A2 Q24682639-0E9D27A2-EA50-4D3B-88ED-9FAAC0B74980 Q26738423-2C3BBEA4-8966-4AB4-92E7-A25D4BE45AB8 Q26738884-7E596780-B8FF-4BE7-8661-B3992F99F0ED Q26749956-75AF26C7-C2F9-43A1-AB68-8DE48EF35A1F Q26768442-9FAF33C9-B624-4E71-B32D-8F61AA1B407E Q27313609-9AA372AE-B8F3-4A49-967D-3697DBEAC74F Q28072540-FC116BAE-EAA0-4E9B-88CF-E21F72D6E892 Q28504750-A78AE71A-C28B-42CC-9243-98FDF4CF6FB6 Q28506393-BAC135A4-61CE-420C-8C4F-5E34A029F0F3 Q28741119-2E994414-5552-4B8B-B955-67D24CC75B2B Q30447427-55731520-4A8A-42B9-8F1C-CA8E2B98AFAB Q33737872-2A0B7666-C3B1-4004-AE09-B6B076124ADE Q34000296-5C015F5F-9CF2-46FC-A8B5-A8CAE202D5BC Q34193235-36EEDF01-A3F7-407D-9B69-5518B4F98149 Q34200023-4644E5EC-2695-464E-8AF1-22C71453F02D Q34292392-3225A7C1-3818-4CD3-86E2-EB49DAF8D567 Q34342895-CF05093C-BCE6-4BFE-9EDF-134C6D394C44 Q34406924-D4E842F5-0232-4BFD-8ADE-C266EABAD0A5 Q34557404-C9B86BF5-CBE0-4EED-B5A7-0804AB264850 Q34628668-F7DDAA82-2698-409E-B76D-90FAAA22D1A2 Q34951480-384A9AE5-2C8E-4126-B778-943019F7808F Q35023878-47E6E0D8-2BC4-4E04-A1C1-19B60D16C877 Q35049421-9FF5BE3D-909C-4049-A65B-55E6CF6D4112 Q35125001-F208D015-C07F-4D59-8DB9-7F6A2DF25D0B Q35239810-517BDA17-2864-480B-92EC-CB09CC557E25 Q35754509-B5A63AF8-8C73-4CFF-BA6E-0FBA6508DC62 Q35806690-2AF59C3F-3459-4A38-B3D8-D6D42E68B017 Q35924931-D7BEBAAD-8F19-4C1A-A7D5-7A360657978D Q36299546-2332E079-F915-47FD-A1F7-E11FE8C718C5 Q36934762-C1410761-DBB8-4695-A4A1-67B3F0B6047B Q36974613-420EC43E-6905-4B5E-A2AB-03973C518DFD Q37171039-04B6DB58-42C9-4BE0-A298-6E4DE6C89B67 Q37181658-87C4DC13-B969-4F72-816C-F2DD7FA87386 Q37418238-3DE34C11-5FC1-4E6E-86DB-0A1D5584B3BE Q37485022-B55EC976-414F-496A-A76B-873AE34425C1 Q37537269-34884592-25E1-4770-AF14-F59098870191

P2860

Reelin expression and glycosylation patterns are altered in Alzheimer's disease

http://www.wikidata.org/entity/Q24541523

description

2006 nî lūn-bûn

@nan

2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Reelin expression and glycosylation patterns are altered in Alzheimer's disease

@ast

Reelin expression and glycosylation patterns are altered in Alzheimer's disease

@en

Reelin expression and glycosylation patterns are altered in Alzheimer's disease

@nl

type

label

Reelin expression and glycosylation patterns are altered in Alzheimer's disease

@ast

Reelin expression and glycosylation patterns are altered in Alzheimer's disease

@en

Reelin expression and glycosylation patterns are altered in Alzheimer's disease

@nl

prefLabel

Reelin expression and glycosylation patterns are altered in Alzheimer's disease

@ast

Reelin expression and glycosylation patterns are altered in Alzheimer's disease

@en

Reelin expression and glycosylation patterns are altered in Alzheimer's disease

@nl

P1433

Q24541523-BE7156DD-11C6-489F-A52A-14155839590E

P1476

Q24541523-1222B894-B7CB-4A87-8BDE-869B49815BE7

P2093

Q24541523-5EF8CC50-B3EF-4D64-B74D-E9E5924F8985

Q24541523-6C730053-812F-481F-8E33-EDEA4EB861A8

Q24541523-850580AC-E7BC-4F4F-8B8A-3F3225CA43AB

Q24541523-CD1A207B-3CC8-4613-9141-05A7AC142661

Q24541523-D1920A27-017D-4D0E-8F9A-1A2D16ED8746

Q24541523-DA7B0404-60E0-40D1-9E5E-43DC78327DBE

Q24541523-E34A60FE-CCC7-45C0-A605-D20CD8AE86C4

P2860

Q24541523-00B3B3C8-D81D-46A0-8633-75DADB736F3A

Q24541523-04C59688-91A9-4CC3-A7BE-6ED7DC90A359

Q24541523-0970A131-4E77-439D-B7E3-E483E026A7A1

Q24541523-0B166940-7700-4350-B8DA-38EF8650CDC7

Q24541523-0E62FB75-1E5A-4BAF-A30C-44AB8890BDB3

Q24541523-2503F0FD-1B9F-4A57-A9DE-4E1AC75CAC2B

Q24541523-27EBD76D-5080-4D11-85AA-83103E4A6A7B

Q24541523-29E3E6D2-4A8C-4CFF-AD48-0416DD4CB1AE

Q24541523-2A15DD26-E6D9-4704-9B83-E827EE9730D8

Q24541523-2CF8AD26-BCA3-4B3F-87CB-061291A9D201

P304

Q24541523-98079AE0-997C-4423-A5AE-3BEE653CAC2B

P31

Q24541523-412C4254-C7B5-4ABA-B6B9-CD2FC9B76FE4

P3181

Q24541523-CFFD5A07-F663-48A8-86C7-C9DBE9A7C791

P356

Q24541523-7A63E3AC-967C-4C04-BD98-32F42D7F7391

P407

Q24541523-B34AAE83-E44A-47AF-B049-3117BFA5B79A

P433

Q24541523-23FADEBF-0FCA-4CBB-A87B-5C429EF20064

P478

Q24541523-93A16F7F-EDE5-40DD-A183-BD31C9D52965

P50

Q24541523-44B3B47B-AFED-49D9-B431-249198A80DC9

Q24541523-49052EC0-9F2D-4A56-AADF-F972722A5066

Q24541523-641B21B1-DB42-4AD7-9A49-1CF24F6F1201

Q24541523-F3F2179E-4B9B-4DD4-A7F2-02E9A0B2ACCB

P577

Q24541523-D2B19F8E-15E0-46EB-85E7-573F957D1342

P5875

Q24541523-E2A7AC70-D3E5-4943-B7DD-74844A51764D

P698

Q24541523-370C07CD-B62A-4DF6-9DAD-A0B8FBA57181

P921

Q24541523-4B2D42C5-9DC9-4555-84EC-63D54DB33F7C

Q24541523-E16DBE43-6D90-445C-8A9E-5F2B19471B00

P932

Q24541523-C7AA5619-CF5D-4811-8157-7A8C1DEFD18E

P3181

P356

PNAS.0601279103

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Reelin expression and glycosylation patterns are altered in Alzheimer's disease

@en

P2093

Arancha Botella-López

http://www.w3.org/2001/XMLSchema#string

Eduardo Soriano

http://www.w3.org/2001/XMLSchema#string

Estrella Gómez-Tortosa

http://www.w3.org/2001/XMLSchema#string

Ferran Burgaya

http://www.w3.org/2001/XMLSchema#string

Jesús M Ureña

http://www.w3.org/2001/XMLSchema#string

Jordi Peña-Casanova

http://www.w3.org/2001/XMLSchema#string

Rafael Blesa

http://www.w3.org/2001/XMLSchema#string

P2860

Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2

Reelin is a ligand for lipoprotein receptors

Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation

Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain

Reelin promoter hypermethylation in schizophrenia

Methodological factors influencing measurement and processing of plasma reelin in humans

A decrease of reelin expression as a putative vulnerability factor in schizophrenia

Reelin secretion from glutamatergic neurons in culture is independent from neurotransmitter regulation

Expression of reelin in adult mammalian blood, liver, pituitary pars intermedia, and adrenal chromaffin cells

Lipoprotein receptors: signaling functions in the brain?

P304

5573-5578

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

369723

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.0601279103

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

Rosalina Gavín

José Antonio Del Río

María-Salud García-Ayllón

P577

2006-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7210924

http://www.w3.org/2001/XMLSchema#string

P698

16567613

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

1414634

http://www.w3.org/2001/XMLSchema#string